TTM
$12.2B
YoY change
+1.4%
5Y CAGR
+2.3%
Peak year (FY2025)
$11.6B
Cumulative EBITDA
$116B
EBITDA history chart for Cigna (CI) from 2016 to 2025
Latest: $11.6B
EBITDA growth chart for Cigna (CI) from 2016 to 2025
Latest: +1.4%
EBITDA history table for Cigna (CI) from 1985 to 2025
| FY2025 | $11.6B | +1.4% | +$161M | ||
| FY2024 | $11.4B | +5.5% | +$600M | ||
| FY2023 | $10.8B | +3.9% | +$410M | ||
| FY2022 | $10.4B | +4.7% | +$473M | ||
| FY2021 | $9.96B | -3.9% | -$405M | ||
| FY2020 | $10.4B | -10.5% | -$1.21B | ||
| FY2019 | $11.6B | +121.9% | +$6.36B | ||
| FY2018 | $5.22B | +19.3% | +$844M | ||
| FY2017 | $4.38B | +23.7% | +$837M | ||
| FY2016 | $3.54B | -6.7% | -$256M | ||
| FY2015 | $3.8B | +4.8% | +$175M | ||
| FY2014 | $3.62B | +506.4% | +$3.02B | ||
| FY2013 | $597M | +6.6% | +$37M | ||
| FY2012 | $560M | -77.7% | -$1.96B | ||
| FY2011 | $2.52B | +7.3% | +$171M | ||
| FY2010 | $2.34B | +0.5% | +$12M | ||
| FY2009 | $2.33B | — | +$2.33B | ||
| FY2008 | $0.00 | — | $0.00 | ||
| FY2007 | $0.00 | -100.0% | -$1.94B | ||
| FY2006 | $1.94B | -3.7% | -$75M | ||
| FY2005 | $2.01B | — | +$2.01B | ||
| FY2004 | $0.00 | -100.0% | -$1.15B | ||
| FY2003 | $1.15B | — | +$1.15B | ||
| FY2002 | $0.00 | — | $0.00 | ||
| FY2001 | $0.00 | -100.0% | -$1.72B | ||
| FY2000 | $1.72B | — | +$1.72B | ||
| FY1999 | $0.00 | — | $0.00 | ||
| FY1998 | $0.00 | — | $0.00 | ||
| FY1997 | $0.00 | — | $0.00 | ||
| FY1996 | $0.00 | — | $0.00 | ||
| FY1995 | $0.00 | — | $0.00 | ||
| FY1994 | $0.00 | — | $0.00 | ||
| FY1993 | $0.00 | — | $0.00 | ||
| FY1992 | $0.00 | — | $0.00 | ||
| FY1991 | $0.00 | — | $0.00 | ||
| FY1990 | $0.00 | — | $0.00 | ||
| FY1989 | $0.00 | -100.0% | -$570M | ||
| FY1988 | $570M | -31.6% | -$263M | ||
| FY1987 | $833M | +18.8% | +$132M | ||
| FY1986 | $701M | -182.0% | +$1.56B | ||
| FY1985 | -$855M | — | — |
- FY2025$11.6B+1.4%
- FY2024$11.4B+5.5%
- FY2023$10.8B+3.9%
- FY2022$10.4B+4.7%
- FY2021$9.96B-3.9%
- FY2020$10.4B-10.5%
- FY2019$11.6B+121.9%
- FY2018$5.22B+19.3%
- FY2017$4.38B+23.7%
- FY2016$3.54B-6.7%
- FY2015$3.8B+4.8%
- FY2014$3.62B+506.4%
- FY2013$597M+6.6%
- FY2012$560M-77.7%
- FY2011$2.52B+7.3%
- FY2010$2.34B+0.5%
- FY2009$2.33B—
- FY2008$0.00—
- FY2007$0.00-100.0%
- FY2006$1.94B-3.7%
- FY2005$2.01B—
- FY2004$0.00-100.0%
- FY2003$1.15B—
- FY2002$0.00—
- FY2001$0.00-100.0%
- FY2000$1.72B—
- FY1999$0.00—
- FY1998$0.00—
- FY1997$0.00—
- FY1996$0.00—
- FY1995$0.00—
- FY1994$0.00—
- FY1993$0.00—
- FY1992$0.00—
- FY1991$0.00—
- FY1990$0.00—
- FY1989$0.00-100.0%
- FY1988$570M-31.6%
- FY1987$833M+18.8%
- FY1986$701M-182.0%
- FY1985-$855M—
EBITDA values are taken from Cigna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Cigna (CI)
According to Cigna's latest reported financial statements, the company's current EBITDA (TTM) is $12.2B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Cigna (CI) EBITDA is $11.6B – edged up 1.4% year-over-year.
Cigna EBITDA compound annual growth for the 2020–2025 (5 years) window is +2.3%, sustaining 4 straight years of year-over-year growth.
The highest annual EBITDA of $11.6B was reported in 2025. The lowest in the available history was -$855M in 1985.
Cigna EBITDA by Year
Cigna EBITDA 2025: $11.6B
Cigna posted EBITDA of $11.6B in 2025, edged up 1.4% from 2024. This figure represents the highest annual value in the available history.
Cigna EBITDA 2024: $11.4B
In 2024, Cigna reported EBITDA of $11.4B, grew 5.5% from 2023.
Cigna EBITDA 2023: $10.8B
Cigna EBITDA in 2023 was $10.8B, edged up 3.9% from 2022.
Cigna EBITDA 2022: $10.4B
2022's EBITDA for Cigna came in at $10.4B, edged up 4.7% from 2021.
Cigna EBITDA 2021: $9.96B
Cigna EBITDA in 2021 was $9.96B.
See more financial history for Cigna (CI).
Sector peers by EBITDA
Healthcare peers of Cigna (CI), ranked by their latest EBITDA
| $41.1B | |
| $28.3B | |
| $27.9B | |
| $24.4B | |
| $23.1B | |
| $17.6B | |
| $16.9B | |
| $11.5B |
- $41.1B
- $28.3B
- $27.9B
- $24.4B
- $23.1B
- $17.6B
- $16.9B
Frequently asked questions
Cigna (CI) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks3.02% TTM
- Dividend Profile2.07% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History2 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.